OtherCommentary
Biopharmaceutical Industry Practices for Sequence Variant Analyses of Recombinant Protein Therapeutics
John Valliere-Douglass, Lisa Marzilli, Aparna Deora, Zhimei Du, Luhong He, Sampath Kumar, Yan-Hui Liu, Hans Martin-Mueller, Charles Nwosu, John Stults, Yan Wang, Sam Yaghmour and Yizhou Zhou
PDA Journal of Pharmaceutical Science and Technology June 2019, pdajpst.2019.010009; DOI: https://doi.org/10.5731/pdajpst.2019.010009
John Valliere-Douglass
1 Seattle Genetics Inc.;
Lisa Marzilli
2 Pfizer;
Aparna Deora
2 Pfizer;
Zhimei Du
3 Merck;
Luhong He
4 Eli Lilly;
Sampath Kumar
5 Takeda;
Yan-Hui Liu
3 Merck;
Hans Martin-Mueller
3 Merck;
Charles Nwosu
5 Takeda;
John Stults
6 Genentech;
Yan Wang
7 Shire;
Sam Yaghmour
8 Amgen;
Yizhou Zhou
9 Biogen
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 79, Issue 3
May/June 2025
Biopharmaceutical Industry Practices for Sequence Variant Analyses of Recombinant Protein Therapeutics
John Valliere-Douglass, Lisa Marzilli, Aparna Deora, Zhimei Du, Luhong He, Sampath Kumar, Yan-Hui Liu, Hans Martin-Mueller, Charles Nwosu, John Stults, Yan Wang, Sam Yaghmour, Yizhou Zhou
PDA Journal of Pharmaceutical Science and Technology Jun 2019, pdajpst.2019.010009; DOI: 10.5731/pdajpst.2019.010009
Biopharmaceutical Industry Practices for Sequence Variant Analyses of Recombinant Protein Therapeutics
John Valliere-Douglass, Lisa Marzilli, Aparna Deora, Zhimei Du, Luhong He, Sampath Kumar, Yan-Hui Liu, Hans Martin-Mueller, Charles Nwosu, John Stults, Yan Wang, Sam Yaghmour, Yizhou Zhou
PDA Journal of Pharmaceutical Science and Technology Jun 2019, pdajpst.2019.010009; DOI: 10.5731/pdajpst.2019.010009
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.